Journal
INTERNATIONAL HEART JOURNAL
Volume 55, Issue 2, Pages 165-168Publisher
INT HEART JOURNAL ASSOC
DOI: 10.1536/ihj.13-268
Keywords
Cardiac fibrosis
Categories
Funding
- Japan Society of the Promotion of Science [23790867]
- Grants-in-Aid for Scientific Research [24591100, 25860613, 23790867] Funding Source: KAKEN
Ask authors/readers for more resources
Accumulating evidence suggests that there are direct interactions between beta-adrenergic and angiotensin II signaling pathways, and beta-blockers protect the heart against angiotensin II-induced cardiac remodeling. Phosphodiesterase 3A (PDE3A) regulates beta-adrenergic receptor/protein kinase A signaling by metabolizing cAMP. Therefore, we hypothesized that overexpressed PDE3A has cardioprotective effects against angiotensin II-induced cardiac remodeling by regulating angiotensin II signaling. In the present study, we used transgenic Mice with cardiac-specific overexpressed PDE3A1. We showed that continuous administration of angiotensin II caused cardiac hypertrophy in the wild-type mouse heart, but not in the transgenic mouse heat. Angiotensin II induced cardiac fibrosis in both wild-type and transgenic mice, but the extent of fibrosis was less in transgenic mice compared to wild-type mice. Moreover, basal expression levels of transforming growth factor-beta were lower in transgenic mouse hearts, and it remained at lower levels after angiotensin II stimulation. These findings suggest that PDE3A protects the heart from angiotensin II-induced cardiac remodeling through its modulation of the functional connection between angiotensin II and transforming growth factor-beta.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available